“New Immunological Markers of Thromboembolic and Hemorrhagic Complications After Coronary Artery Bypass Grafting”. 2018. Asian Journal of Pharmaceutics (AJP) 11 (04). https://doi.org/10.22377/ajp.v11i04.1748.